EarningsQ3 2025 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q3 2025 Earnings Report

0 Followers

MX:JAZZN Q3 2025 EPS Results

Actual EPS$147.66

Consensus EPS$107.99

Beat/MissBeat by +$39.67

One Year Ago EPS$120.05

Actual Revenue$20.45B

Expected Revenue$20.18B

Beat/MissBeat by +$272.25M

YoY Revenue Growth+6.74%

QuarterQ3 2025

Date11/05/2025

TimeAfter Close

Conference CallWednesday, November 5, 2025

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	116.93 / -	147.66	―
Aug 03, 2026	2026 (Q2)	112.15 / 103.71	-149.839	169.21% (+253.55)
May 05, 2026	2026 (Q1)	84.29 / 115.15	30.513	277.38% (+84.64)
Feb 24, 2026	2025 (Q4)	118.38 / 120.60	119.871	0.61% (+0.73)
Nov 05, 2025	2025 (Q3)	107.99 / 147.66	120.053	23.00% (+27.61)
Aug 05, 2025	2025 (Q2)	-138.14 / -149.84	96.26	-255.66% (-246.10)
May 06, 2025	2025 (Q1)	84.60 / 30.51	48.675	-37.31% (-18.16)
Feb 25, 2025	2024 (Q4)	106.47 / 119.87	91.175	31.47% (+28.70)
Nov 06, 2024	2024 (Q3)	99.86 / 120.05	87.906	36.57% (+32.15)
Jul 31, 2024	2024 (Q2)	89.40 / 96.26	81.912	17.52% (+14.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed